Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-18

Clinical Trial Update: A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting

View source ↗

Summary

A pharmacovigilance study evaluating how tigecycline (Tygacil) is prescribed in routine US healthcare settings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TYGACIL (tigecycline)

Snippet

Sponsor: Pfizer | Conditions: Infection | Status: COMPLETED | Results posted: 2011-07-18